University College London: Weight Loss Drug Semaglutide Helps Patients Who Do Not Respond to Bariatric Surgery
May 22, 2026
May 22, 2026
LONDON, England, May 22 (TNSjou) -- The University College London posted the following news:
* * *
Weight loss drug semaglutide helps patients who do not respond to bariatric surgery
New UCL research supports use of the weight loss drug semaglutide for patients who do not get enough benefit from bariatric surgery.
Metabolic/bariatric surgery is a highly effective treatment for people living with severe obesity and/or metabolic health conditions . . .
* * *
Weight loss drug semaglutide helps patients who do not respond to bariatric surgery
New UCL research supports use of the weight loss drug semaglutide for patients who do not get enough benefit from bariatric surgery.
Metabolic/bariatric surgery is a highly effective treatment for people living with severe obesity and/or metabolic health conditions . . .